NDC 50090-6532-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6532
- Requested NDC
- 50090-6532-01
- Package NDCs from labels
- 50090-6532-0, 50090-6532-1, 50090-6532-8, 50090-6532-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-06-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2023-06-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6532-0 | Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 50090-6532-1 | Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 50090-6532-8 | Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6532 | HYDROCHLOROTHIAZIDE TABLET [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 3 package rows | 20230630_b56a3559-6eb2-4a8d-a9a4-232d2ff0febe.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6532-0 | EA - Each | 50090-6532 | 305f73b3-bef6-4502-acdf-0d22c2e16060 | 1 | 2023-08-08 |
| 50090-6532-1 | EA - Each | 50090-6532 | 16bda394-a4bc-40a3-952d-616a27a616ae | 1 | 2023-08-08 |
| 50090-6532-8 | EA - Each | 50090-6532 | 73735477-5b2b-445b-9e22-2a453167b0f8 | 1 | 2023-08-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 868b1442-c412-4ee8-9798-f2408cd2249a | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 191d5710-7b8a-0b61-e063-6394a90afd41 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 408e797a-2cf3-4ee6-9f9b-179a8cf3d799 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unit Dose Solutions, Inc. | 54f027ea-0a6e-7920-e063-6394a90ab6ae | 2026-06-23 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 03b11335-2e88-2f7b-e063-6394a90afe2a | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | eac57b4c-e79b-8d35-e053-2a95a90a9d25 | 2026-06-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Leading Pharma, LLC | 8c868894-667e-4a51-906a-838d63e420ba | 2026-06-12 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | cdf59426-2a2f-4a60-943a-e6cef3eb31e1 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5eabb13d-f6fd-4091-9909-c4f0c5922289 | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | 099496f1-4e2d-8d21-e063-6294a90af695 | 2026-06-03 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 43425ec7-a2c0-41d8-b759-b7b5918949ce | 2026-06-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | de5e7c85-5bf5-5b5f-e053-2995a90a1fba | 2026-06-01 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 6eab1c0a-9328-42a6-8eae-d4e105c54716 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 85494404-484c-45a1-8487-f9eb2a76490d | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Coupler LLC | 52b90789-2902-3ab9-e063-6394a90a5abb | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | 5956a107-0f7b-49e7-b9c9-36790349b06e | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals, Inc. | 5aa18b0b-4688-493a-a5ae-cb056ea6c0e3 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | 9207c3bc-e12e-4017-8b85-0f928e744f64 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | fc4d7d0e-78a6-4d7e-ba53-aeeb008aa2dc | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals Inc | 52332190-2a12-d205-e063-6394a90ab7c5 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.